Pharma-Bio Serv Income Statement (2010-2026) | PBSV

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Apr2021	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Jan2025	Apr2025	Jul2025	Oct2025	Jan2026
Revenue & cost
Revenue (Quarter)	5.04M	4.99M	5.60M	5.02M	4.97M	4.77M	4.64M	4.24M	4.56M	4.58M	3.60M	2.38M	2.38M	2.42M	2.33M	2.47M	2.42M	1.96M	2.15M	2.29M
Cost of Revenue (Quarter)	3.75M	3.73M	4.10M	3.77M	3.75M	3.46M	3.53M	3.00M	3.22M	3.03M	2.67M	1.84M	1.76M	1.78M	1.61M	1.70M	1.60M	1.39M	1.40M	1.57M
Gross Profit (Quarter)	1.29M	1.26M	1.50M	1.24M	1.22M	1.31M	1.11M	1.24M	1.35M	1.55M	0.93M	0.54M	0.62M	0.64M	0.73M	0.77M	0.82M	0.57M	0.75M	0.72M
Operating items
Selling, General & Administrative (Quarter)	1.03M	0.89M	6.30M	0.89M	0.94M	0.94M	0.94M	0.91M	0.97M	1.09M	0.98M	0.97M	0.93M	1.02M	0.88M	0.86M	0.92M	0.89M	0.88M	0.82M
Operating Expenses (Quarter)	1.03M	0.89M	6.30M	0.89M	0.94M	0.94M	0.94M	0.91M	0.97M	1.09M	0.98M	0.97M	0.93M	1.02M	0.88M	0.86M	0.92M	0.89M	0.88M	0.82M
Operating Income (Quarter)	0.26M	0.36M	-4.80M	0.36M	0.28M	0.37M	0.17M	0.33M	0.38M	0.46M	-0.05M	-0.44M	-0.31M	-0.38M	-0.15M	-0.09M	-0.10M	-0.31M	-0.13M	-0.09M
EBIT (Quarter)	0.26M	0.36M	-4.80M	0.36M	0.28M	0.37M	0.17M	0.33M	0.38M	0.46M	-0.05M	-0.44M	-0.31M	-0.38M	-0.15M	-0.09M	-0.10M	-0.31M	-0.13M	-0.09M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.02M	1.95M	0.00M	615.00	0.00M	-0.05M	0.06M	0.25M	0.19M	0.13M
Non Operating Income (Quarter)	0.02M	1.95M	0.00M	615.00	0.00M	-0.05M	0.06M	0.25M	0.19M	0.13M
Net income details
EBT (Quarter)	0.29M	2.31M	-4.80M	0.36M	0.29M	0.32M	0.23M	0.58M	0.57M	0.59M	-0.05M	-0.26M	-0.19M	-0.29M	-0.01M	0.01M	0.10M	-0.21M	0.00M	0.04M
Tax Provisions (Quarter)	0.05M	0.04M	0.08M	0.05M	0.05M	0.03M	0.06M	0.15M	0.17M	0.06M	-687.00	0.01M	0.02M	0.02M	-0.03M	0.00M	0.01M	0.00M	0.00M	0.00M
Profit After Tax (Quarter)	0.24M	2.28M	-4.87M	0.31M	0.24M	0.29M	0.34M	0.33M	0.38M	0.46M	-0.05M	-0.27M	-0.31M	-0.38M	0.36M	0.01M	-0.10M	-0.31M	0.40M	-0.09M
Income from Continuing Operations (Quarter)	0.24M	2.28M	-4.87M	0.31M	0.24M	0.29M	0.17M	0.43M	0.40M	0.53M	-0.05M	-0.27M	-0.21M	-0.31M	0.02M	0.01M	0.10M	-0.21M	-102.00	0.03M
Consolidated Net Income (Quarter)	0.24M	2.28M	-4.87M	0.31M	0.24M	0.29M	0.17M	0.43M	0.40M	0.53M	-0.05M	-0.27M	-0.21M	-0.31M	0.02M	0.01M	0.10M	-0.21M	-102.00	0.03M
Income towards Parent Company (Quarter)	0.24M	2.28M	-4.87M	0.31M	0.24M	0.29M	0.17M	0.43M	0.40M	0.53M	-0.05M	-0.27M	-0.21M	-0.31M	0.02M	0.01M	0.10M	-0.21M	-102.00	0.03M
Net Income towards Common Stockholders (Quarter)	0.24M	2.28M	-4.87M	0.31M	0.24M	0.29M	0.17M	0.43M	0.40M	0.53M	-0.05M	-0.27M	-0.21M	-0.31M	0.02M	0.01M	0.10M	-0.21M	-102.00	0.03M
Additional items
EPS (Basic) (Quarter)	0.01	0.10	-0.21	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.00	-0.01	-0.01	-0.01	0.00	0.00	0.00	-0.01	0.00	0.00
EPS (Weighted Average and Diluted) (Quarter)	0.01	0.10	-0.21	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.00	-0.01	-0.01	0.01	-0.07	0.00	0.00	0.01	-0.01	0.00
Shares Outstanding (Weighted Average) (Quarter)	23.03M	23.03M	23.03M	22.98M	22.99M	22.95M	23.00M	22.95M	22.95M	22.97M	22.97M	22.96M	22.96M	22.96M	22.97M	22.96M	22.93M	22.93M	22.95M	22.91M
Shares Outstanding (Diluted Average) (Quarter)	23.18M	23.17M	23.16M	23.03M	23.03M	23.03M	23.03M	22.96M	23.02M	22.98M	23.00M	22.99M	22.98M	22.96M	22.97M	22.96M	22.94M	22.96M	22.96M	22.91M
EBITDA (Quarter)	0.26M	0.36M	-4.80M	0.36M	0.28M	0.37M	0.17M	0.33M	0.38M	0.46M	-0.05M	-0.44M	-0.31M	-0.38M	-0.15M	-0.09M	-0.10M	-0.31M	-0.13M	-0.09M
Interest Expenses (Quarter)
Tax Rate (Quarter)	15.95%	1.65%	-1.58%	14.37%	15.79%	8.80%	24.96%	25.86%	29.34%	10.42%	1.44%	-5.02%	-10.99%	-6.55%	208.50%	11.55%	5.46%	-2.29%	102.40%	9.95%

Research Tools

Pharma-Bio Serv Income Statement (2010-2026) | PBSV

Create an account

Sign In

Reset Password